Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 109 of 200 · By data quality, then INN

  1. tinidazole

    TINDAMAX

    ORAL FDA: approved

  2. tinzaparin sodium

    INNOHEP

    INJECTION FDA: approved

  3. tioconazole

    VAGISTAT-1

    TOPICAL FDA: approved

  4. tiotropium bromide

    SPIRIVA RESPIMAT

    INHALATION FDA: approved

  5. tipiracil hydrochloride

    LONSURF

    ORAL FDA: approved

  6. tipranavir

    APTIVUS

    ORAL FDA: approved · EMA: approved

    J05AE09

  7. tirofiban hydrochloride

    AGGRASTAT

    INJECTION FDA: approved

  8. tirzepatide

    MOUNJARO

    SUBCUTANEOUS FDA: approved · EMA: approved · PMDA: approved

    A10BX16

  9. tislelizumab-jsgr

    TEVIMBRA

    SOLUTION FDA: approved

  10. tisotumab vedotin-tftv

    TIVDAK

    INJECTION FDA: approved

  11. tivozanib hydrochloride

    FOTIVDA

    ORAL FDA: approved

  12. tizanidine hydrochloride

    TIZANIDINE HYDROCHLORIDE

    ORAL FDA: approved

  13. tocainide hydrochloride

    TONOCARD

    ORAL FDA: approved

  14. tocilizumab

    ACTEMRA Hoffmann-La Roche

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L04AC07

  15. tocilizumab-aazg

    TYENNE

    SUBCUTANEOUS FDA: approved

  16. tocilizumab-anoh

    AVTOZMA

    IV (INFUSION) FDA: approved

  17. tocilizumab-bavi

    TOFIDENCE

    INJECTION FDA: approved

  18. tofacitinib

    XELJANZ Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AF01

  19. tofacitinib citrate

    XELJANZ INITIAL APPROVAL

    ORAL FDA: approved · PMDA: approved

  20. tofersen

    QALSODY

    INTRATHECAL FDA: approved · EMA: approved · PMDA: approved

    N07XX22

  21. tolazamide

    TOLAZAMIDE

    ORAL FDA: approved

  22. tolazoline hydrochloride

    PRISCOLINE

    INJECTION FDA: approved

  23. tolbutamide

    TOLBUTAMIDE

    ORAL FDA: approved

  24. tolbutamide sodium

    ORINASE DIAGNOSTIC

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.